News and Events

  • Monday, November 18, 2013
    • Genelux Corporation’s GL-ONC1 selected by Elsevier among its “Top 10 Oncology Projects to Watch”… more
  • Thursday, June 14, 2012
    • Genelux Corporation Announces First Patient Dosed in Phase I Combination Clinical Trial of
    GL-ONC1… more
  • Thursday, May 31, 2012
    • Genelux Corporation Announces Treatment of First Patient in Phase I/II Clinical Trial of GL-ONC1 in Advanced Peritoneal Cavity Cancers… more
  • Wednesday, May 30, 2012
    • Genelux Corporation Announces Phase I Data Presentation at 2012 ASCO Annual Meeting of GL-ONC1, its Oncolytic Virus Lead Product Candidate… more
  • Thursday, August 4, 2011
    • Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors… more
  • Monday, June 6, 2011
    • Preliminary results of Phase I Clinical Trial involving Intravenous Administration of GL-ONC1 to Patients with Advanced Solid Tumor Cancers presented at ASCO… more
  • Monday, January 24, 2011
    • Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive…more
  • Sunday, November 14, 2010
    • Genelux Awarded Therapeutic Discovery Project Grant…more